Загрузка...

Eli Lilly spent the last year suing compounding pharmacies and telehealth companies

Eli Lilly spent the last year suing compounding pharmacies and telehealth companies. Mochi, Henry Meds, Fella, and more. Now Eli Lilly's name is on a research paper about compounded GLP-1s, and every author I could find works for the company. Here's the part I can't stop thinking about. It published April 30. The same day the FDA announced it wants to permanently end large-scale (503B) compounding of semaglutide and tirzepatide. Coincidence? Maybe. Full breakdown on Substack this week. Tell me what you see 👇 #tirz #compounding #glp1community #elililly

Видео Eli Lilly spent the last year suing compounding pharmacies and telehealth companies канала Tirzepatide Tales with Maria
Яндекс.Метрика
Все заметки Новая заметка Страницу в заметки
Страницу в закладки Мои закладки
На информационно-развлекательном портале SALDA.WS применяются cookie-файлы. Нажимая кнопку Принять, вы подтверждаете свое согласие на их использование.
О CookiesНапомнить позжеПринять